Global Vitamin K Antagonists (VKA) Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application
Report Code: KNJ1408858 No. of Pages: 103 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Vitamin K is a kind of substance with biological activity of leaf green quinone. Market Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Vitamin K Antagonists (VKA) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. Rising demand from Asia-Pacific region a major driver for the growth of the market. Report Scope This report aims to provide a comprehensive presentation of the global market for Vitamin K Antagonists (VKA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin K Antagonists (VKA). The Vitamin K Antagonists (VKA) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Vitamin K Antagonists (VKA) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin K Antagonists (VKA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. Market Segmentation This report covers the Vitamin K Antagonists (VKA) segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. By Company Sanofi Bristol-Myers Squibb Bayer Johnson & Johnson Genentech (Roche) Boehringer Ingelheim Lilly Daiichi Sankyo Otsuka AstraZeneca Pfizer Aspen The Medicines Company Vitamin K Antagonists (VKA) Segment by Type Oral Vitamin K Antagonists Injection Vitamin K Antagonists Vitamin K Antagonists (VKA) Segment by Application VTE ACS/MI AF Others Vitamin K Antagonists (VKA) Segment by Region North America (USA and Canada) Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) South America (Mexico, Brazil, Rest of South America) Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA) Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Vitamin K Antagonists (VKA) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report Informative and detailed data, sales, revenue, average price, historical and forecast data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment. This report will help stakeholders to understand the global industry status and trends of Vitamin K Antagonists (VKA) and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly. This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Vitamin K Antagonists (VKA) industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Core Chapters Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size by type for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Two: Detailed analysis of Vitamin K Antagonists (VKA) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc. Chapter Three: Sales, revenue of Vitamin K Antagonists (VKA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world. Chapter Four: Introduces market segments by application, market size by application for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country. Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter Twelve: Research Findings and Conclusion
1 Vitamin K Antagonists (VKA) Market Overview 1.1 Vitamin K Antagonists (VKA) Product Overview 1.2 Vitamin K Antagonists (VKA) Market Segment by Type 1.2.1 Oral Vitamin K Antagonists 1.2.2 Injection Vitamin K Antagonists 1.3 Global Vitamin K Antagonists (VKA) Market Size by Type 1.3.1 Global Vitamin K Antagonists (VKA) Market Size Overview by Type (2017-2028) 1.3.2 Global Vitamin K Antagonists (VKA) Historic Market Size Review by Type (2017-2022) 1.3.2.1 Global Vitamin K Antagonists (VKA) Sales Breakdown in Volume by Type (2017-2022) 1.3.2.2 Global Vitamin K Antagonists (VKA) Sales Breakdown in Value by Type (2017-2022) 1.3.2.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017-2022) 1.3.3 Global Vitamin K Antagonists (VKA) Forecasted Market Size by Type (2023-2028) 1.3.3.1 Global Vitamin K Antagonists (VKA) Sales Breakdown in Volume by Type (2023-2028) 1.3.3.2 Global Vitamin K Antagonists (VKA) Sales Breakdown in Value by Type (2023-2028) 1.3.3.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2023-2028) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Vitamin K Antagonists (VKA) Sales Breakdown by Type (2017-2022) 1.4.2 Europe Vitamin K Antagonists (VKA) Sales Breakdown by Type (2017-2022) 1.4.3 Asia-Pacific Vitamin K Antagonists (VKA) Sales Breakdown by Type (2017-2022) 1.4.4 Latin America Vitamin K Antagonists (VKA) Sales Breakdown by Type (2017-2022) 1.4.5 Middle East and Africa Vitamin K Antagonists (VKA) Sales Breakdown by Type (2017-2022) 2 Global Vitamin K Antagonists (VKA) Market Competition by Company 2.1 Global Top Players by Vitamin K Antagonists (VKA) Sales (2017-2022) 2.2 Global Top Players by Vitamin K Antagonists (VKA) Revenue (2017-2022) 2.3 Global Top Players Vitamin K Antagonists (VKA) Price (2017-2022) 2.4 Global Top Manufacturers Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Sales Area, Product Type 2.5 Vitamin K Antagonists (VKA) Market Competitive Situation and Trends 2.5.1 Vitamin K Antagonists (VKA) Market Concentration Rate (2017-2022) 2.5.2 Global 5 and 10 Largest Manufacturers by Vitamin K Antagonists (VKA) Sales and Revenue in 2021 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2021) 2.7 Date of Key Manufacturers Enter into Vitamin K Antagonists (VKA) Market 2.8 Key Manufacturers Vitamin K Antagonists (VKA) Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Vitamin K Antagonists (VKA) Status and Outlook by Region 3.1 Global Vitamin K Antagonists (VKA) Market Size and CAGR by Region: 2017 VS 2021 VS 2028 3.2 Global Vitamin K Antagonists (VKA) Historic Market Size by Region 3.2.1 Global Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2022) 3.2.2 Global Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2022) 3.2.3 Global Vitamin K Antagonists (VKA) Sales (Volume & Value) Price and Gross Margin (2017-2022) 3.3 Global Vitamin K Antagonists (VKA) Forecasted Market Size by Region 3.3.1 Global Vitamin K Antagonists (VKA) Sales in Volume by Region (2023-2028) 3.3.2 Global Vitamin K Antagonists (VKA) Sales in Value by Region (2023-2028) 3.3.3 Global Vitamin K Antagonists (VKA) Sales (Volume & Value), Price and Gross Margin (2023-2028) 4 Global Vitamin K Antagonists (VKA) by Application 4.1 Vitamin K Antagonists (VKA) Market Segment by Application 4.1.1 VTE 4.1.2 ACS/MI 4.1.3 AF 4.1.4 Others 4.2 Global Vitamin K Antagonists (VKA) Market Size by Application 4.2.1 Global Vitamin K Antagonists (VKA) Market Size Overview by Application (2017-2028) 4.2.2 Global Vitamin K Antagonists (VKA) Historic Market Size Review by Application (2017-2022) 4.2.2.1 Global Vitamin K Antagonists (VKA) Sales Breakdown in Volume, by Application (2017-2022) 4.2.2.2 Global Vitamin K Antagonists (VKA) Sales Breakdown in Value, by Application (2017-2022) 4.2.2.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017-2022) 4.2.3 Global Vitamin K Antagonists (VKA) Forecasted Market Size by Application (2023-2028) 4.2.3.1 Global Vitamin K Antagonists (VKA) Sales Breakdown in Volume, by Application (2023-2028) 4.2.3.2 Global Vitamin K Antagonists (VKA) Sales Breakdown in Value, by Application (2023-2028) 4.2.3.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2023-2028) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Vitamin K Antagonists (VKA) Sales Breakdown by Application (2017-2022) 4.3.2 Europe Vitamin K Antagonists (VKA) Sales Breakdown by Application (2017-2022) 4.3.3 Asia-Pacific Vitamin K Antagonists (VKA) Sales Breakdown by Application (2017-2022) 4.3.4 Latin America Vitamin K Antagonists (VKA) Sales Breakdown by Application (2017-2022) 4.3.5 Middle East and Africa Vitamin K Antagonists (VKA) Sales Breakdown by Application (2017-2022) 5 North America Vitamin K Antagonists (VKA) by Country 5.1 North America Vitamin K Antagonists (VKA) Historic Market Size by Country 5.1.1 North America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2022) 5.1.2 North America Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2022) 5.2 North America Vitamin K Antagonists (VKA) Forecasted Market Size by Country 5.2.1 North America Vitamin K Antagonists (VKA) Sales in Volume by Country (2023-2028) 5.2.2 North America Vitamin K Antagonists (VKA) Sales in Value by Country (2023-2028) 6 Europe Vitamin K Antagonists (VKA) by Country 6.1 Europe Vitamin K Antagonists (VKA) Historic Market Size by Country 6.1.1 Europe Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2022) 6.1.2 Europe Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2022) 6.2 Europe Vitamin K Antagonists (VKA) Forecasted Market Size by Country 6.2.1 Europe Vitamin K Antagonists (VKA) Sales in Volume by Country (2023-2028) 6.2.2 Europe Vitamin K Antagonists (VKA) Sales in Value by Country (2023-2028) 7 Asia-Pacific Vitamin K Antagonists (VKA) by Region 7.1 Asia-Pacific Vitamin K Antagonists (VKA) Historic Market Size by Region 7.1.1 Asia-Pacific Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2022) 7.1.2 Asia-Pacific Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2022) 7.2 Asia-Pacific Vitamin K Antagonists (VKA) Forecasted Market Size by Region 7.2.1 Asia-Pacific Vitamin K Antagonists (VKA) Sales in Volume by Region (2023-2028) 7.2.2 Asia-Pacific Vitamin K Antagonists (VKA) Sales in Value by Region (2023-2028) 8 Latin America Vitamin K Antagonists (VKA) by Country 8.1 Latin America Vitamin K Antagonists (VKA) Historic Market Size by Country 8.1.1 Latin America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2022) 8.1.2 Latin America Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2022) 8.2 Latin America Vitamin K Antagonists (VKA) Forecasted Market Size by Country 8.2.1 Latin America Vitamin K Antagonists (VKA) Sales in Volume by Country (2023-2028) 8.2.2 Latin America Vitamin K Antagonists (VKA) Sales in Value by Country (2023-2028) 9 Middle East and Africa Vitamin K Antagonists (VKA) by Country 9.1 Middle East and Africa Vitamin K Antagonists (VKA) Historic Market Size by Country 9.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2022) 9.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2022) 9.2 Middle East and Africa Vitamin K Antagonists (VKA) Forecasted Market Size by Country 9.2.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales in Volume by Country (2023-2028) 9.2.2 Middle East and Africa Vitamin K Antagonists (VKA) Sales in Value by Country (2023-2028) 10 Company Profiles and Key Figures in Vitamin K Antagonists (VKA) Business 10.1 Sanofi 10.1.1 Sanofi Corporation Information 10.1.2 Sanofi Introduction and Business Overview 10.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered 10.1.5 Sanofi Recent Development 10.2 Bristol-Myers Squibb 10.2.1 Bristol-Myers Squibb Corporation Information 10.2.2 Bristol-Myers Squibb Introduction and Business Overview 10.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered 10.2.5 Bristol-Myers Squibb Recent Development 10.3 Bayer 10.3.1 Bayer Corporation Information 10.3.2 Bayer Introduction and Business Overview 10.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered 10.3.5 Bayer Recent Development 10.4 Johnson & Johnson 10.4.1 Johnson & Johnson Corporation Information 10.4.2 Johnson & Johnson Introduction and Business Overview 10.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered 10.4.5 Johnson & Johnson Recent Development 10.5 Genentech (Roche) 10.5.1 Genentech (Roche) Corporation Information 10.5.2 Genentech (Roche) Introduction and Business Overview 10.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered 10.5.5 Genentech (Roche) Recent Development 10.6 Boehringer Ingelheim 10.6.1 Boehringer Ingelheim Corporation Information 10.6.2 Boehringer Ingelheim Introduction and Business Overview 10.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered 10.6.5 Boehringer Ingelheim Recent Development 10.7 Lilly 10.7.1 Lilly Corporation Information 10.7.2 Lilly Introduction and Business Overview 10.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered 10.7.5 Lilly Recent Development 10.8 Daiichi Sankyo 10.8.1 Daiichi Sankyo Corporation Information 10.8.2 Daiichi Sankyo Introduction and Business Overview 10.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered 10.8.5 Daiichi Sankyo Recent Development 10.9 Otsuka 10.9.1 Otsuka Corporation Information 10.9.2 Otsuka Introduction and Business Overview 10.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered 10.9.5 Otsuka Recent Development 10.10 AstraZeneca 10.10.1 AstraZeneca Corporation Information 10.10.2 AstraZeneca Introduction and Business Overview 10.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered 10.10.5 AstraZeneca Recent Development 10.11 Pfizer 10.11.1 Pfizer Corporation Information 10.11.2 Pfizer Introduction and Business Overview 10.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.11.4 Pfizer Vitamin K Antagonists (VKA) Products Offered 10.11.5 Pfizer Recent Development 10.12 Aspen 10.12.1 Aspen Corporation Information 10.12.2 Aspen Introduction and Business Overview 10.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.12.4 Aspen Vitamin K Antagonists (VKA) Products Offered 10.12.5 Aspen Recent Development 10.13 The Medicines Company 10.13.1 The Medicines Company Corporation Information 10.13.2 The Medicines Company Introduction and Business Overview 10.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022) 10.13.4 The Medicines Company Vitamin K Antagonists (VKA) Products Offered 10.13.5 The Medicines Company Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Vitamin K Antagonists (VKA) Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Vitamin K Antagonists (VKA) Industrial Chain Analysis 11.4 Vitamin K Antagonists (VKA) Market Dynamics 11.4.1 Vitamin K Antagonists (VKA) Industry Trends 11.4.2 Vitamin K Antagonists (VKA) Market Drivers 11.4.3 Vitamin K Antagonists (VKA) Market Challenges 11.4.4 Vitamin K Antagonists (VKA) Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Vitamin K Antagonists (VKA) Distributors 12.3 Vitamin K Antagonists (VKA) Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com